期刊
ORGANIC & BIOMOLECULAR CHEMISTRY
卷 13, 期 18, 页码 5279-5284出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c5ob00211g
关键词
-
资金
- Cancer Research UK
- Pfizer Global Research and Development
- Cancer Research UK [15751] Funding Source: researchfish
Regioselective sulfamoylation of primary hydroxyl groups enabled a 5-step synthesis (overall yield 17%) of the first reported small molecule inhibitor of sulfatase-1 and 2, ((2S, 3R, 4R, 5S, 6R)-4,5-dihydroxy-2-methoxy-6-((sulfamoyloxy)methyl) tetrahydro-2H-pyran-3-yl) sulfamic acid, which obviated the use of hydroxyl protecting groups and is a marked improvement on the reported 9-step synthesis (overall yield 9%) employing hazardous trifluoromethylsulfonyl azide. The sulfamoylation methodology was used to prepare a range of derivatives of 1, and inhibition data was generated for Sulf-2, ARSA and ARSB.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据